

Bausch + Lomb stock drops 10% following sudden CEO departure, despite raising full-year 2026 EBITDA guidance.
You can purchase shares of Bausch Health Companies (NYSE:BHC) through any online brokerage.
There are no as such competitors for Bausch Health Companies.
Bausch Health Companies has a consensus price target of $7.14.
The stock price for Bausch Health Companies (NYSE: BHC) is $6.21 last updated October 26, 2026 at 4:24 PM EDT.
There are no upcoming dividends for Bausch Health Companies.
Bausch Health Companies does not have any upcoming earnings scheduled.
There is no upcoming split for Bausch Health Companies.
Bausch Health Companies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in...